Mathematical model for IL-2-based cancer immunotherapy
From MaRDI portal
Publication:6566666
DOI10.1016/j.mbs.2024.109187zbMath1545.92052MaRDI QIDQ6566666
Jianjun Paul Tian, Tuan Anh Phan, John C. Dallon, Megan Dixon
Publication date: 3 July 2024
Published in: Mathematical Biosciences (Search for Journal in Brave)
Medical applications (general) (92C50) Global stability of solutions to ordinary differential equations (34D23) Numerical bifurcation problems (65P30)
Cites Work
- A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy
- Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy
- Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer
- Modeling immunotherapy of the tumor -- immune interaction
- Mathematical modeling of tumor-immune cell interactions
- A methodology for performing global uncertainty and sensitivity analysis in systems biology
- A mathematical model of cancer treatment by immunotherapy
- Multi-method global sensitivity analysis of mathematical models
- Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
- A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer
- Hopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. I
- Stochastic dynamics of human papillomavirus delineates cervical cancer progression
- A stochastic framework for evaluating CAR T cell therapy efficacy and variability
This page was built for publication: Mathematical model for IL-2-based cancer immunotherapy